These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 19506137)

  • 1. Effect of changes in fat availability on exercise capacity in McArdle disease.
    Andersen ST; Jeppesen TD; Taivassalo T; Sveen ML; Heinicke K; Haller RG; Vissing J
    Arch Neurol; 2009 Jun; 66(6):762-6. PubMed ID: 19506137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fat metabolism during exercise in patients with McArdle disease.
    Ørngreen MC; Jeppesen TD; Andersen ST; Taivassalo T; Hauerslev S; Preisler N; Haller RG; van Hall G; Vissing J
    Neurology; 2009 Feb; 72(8):718-24. PubMed ID: 19237700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactate and Energy Metabolism During Exercise in Patients With Blocked Glycogenolysis (McArdle Disease).
    Ørngreen MC; Jeppesen TD; Taivassalo T; Hauerslev S; Preisler N; Heinicke K; Haller RG; Vissing J; van Hall G
    J Clin Endocrinol Metab; 2015 Aug; 100(8):E1096-104. PubMed ID: 26030324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oral sucrose shortly before exercise on work capacity in McArdle disease.
    Andersen ST; Haller RG; Vissing J
    Arch Neurol; 2008 Jun; 65(6):786-9. PubMed ID: 18541798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle glycogen unavailability and fat oxidation rate during exercise: Insights from McArdle disease.
    Rodriguez-Lopez C; Santalla A; Valenzuela PL; Real-Martínez A; Villarreal-Salazar M; Rodriguez-Gomez I; Pinós T; Ara I; Lucia A
    J Physiol; 2023 Feb; 601(3):551-566. PubMed ID: 36370371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response effect of pre-exercise carbohydrates under muscle glycogen unavailability: Insights from McArdle disease.
    Valenzuela PL; Santalla A; Alejo LB; Merlo A; Bustos A; Castellote-Bellés L; Ferrer-Costa R; Maffiuletti NA; Barranco-Gil D; Pinós T; Lucia A
    J Sport Health Sci; 2024 May; 13(3):398-408. PubMed ID: 38030066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of substrate utilization, manipulated by nicotinic acid, on excess postexercise oxygen consumption.
    Trost S; Wilcox A; Gillis D
    Int J Sports Med; 1997 Feb; 18(2):83-8. PubMed ID: 9081262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of fuels on exercise capacity in muscle phosphoglycerate mutase deficiency.
    Vissing J; Quistorff B; Haller RG
    Arch Neurol; 2005 Sep; 62(9):1440-3. PubMed ID: 16157752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of adipose tissue lipolysis increases intramuscular lipid use in type 2 diabetic patients.
    van Loon LJ; Manders RJ; Koopman R; Kaastra B; Stegen JH; Gijsen AP; Saris WH; Keizer HA
    Diabetologia; 2005 Oct; 48(10):2097-107. PubMed ID: 16096823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal muscle fat metabolism after exercise in humans: influence of fat availability.
    Kimber NE; Cameron-Smith D; McGee SL; Hargreaves M
    J Appl Physiol (1985); 2013 Jun; 114(11):1577-85. PubMed ID: 23519231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of oral sucrose on exercise tolerance in patients with McArdle's disease.
    Vissing J; Haller RG
    N Engl J Med; 2003 Dec; 349(26):2503-9. PubMed ID: 14695410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired glycogen breakdown and synthesis in phosphoglucomutase 1 deficiency.
    Preisler N; Cohen J; Vissing CR; Madsen KL; Heinicke K; Sharp LJ; Phillips L; Romain N; Park SY; Newby M; Wyrick P; Mancias P; Galbo H; Vissing J; Haller RG
    Mol Genet Metab; 2017 Nov; 122(3):117-121. PubMed ID: 28882528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No effect of oral ketone ester supplementation on exercise capacity in patients with McArdle disease and healthy controls: A randomized placebo-controlled cross-over study.
    Løkken N; Storgaard JH; Revsbech KL; Voermans NC; Van Hall G; Vissing J; Ørngreen MC
    J Inherit Metab Dis; 2022 May; 45(3):502-516. PubMed ID: 35150142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic profiles of exercise in patients with McArdle disease or mitochondrial myopathy.
    Delaney NF; Sharma R; Tadvalkar L; Clish CB; Haller RG; Mootha VK
    Proc Natl Acad Sci U S A; 2017 Aug; 114(31):8402-8407. PubMed ID: 28716914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No effect of triheptanoin on exercise performance in McArdle disease.
    Madsen KL; Laforêt P; Buch AE; Stemmerik MG; Ottolenghi C; Hatem SN; Raaschou-Pedersen DT; Poulsen NS; Atencio M; Luton MP; Ceccaldi A; Haller RG; Quinlivan R; Mochel F; Vissing J
    Ann Clin Transl Neurol; 2019 Oct; 6(10):1949-1960. PubMed ID: 31520525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercising with blocked muscle glycogenolysis: Adaptation in the McArdle mouse.
    Nielsen TL; Pinós T; Brull A; Vissing J; Krag TO
    Mol Genet Metab; 2018 Jan; 123(1):21-27. PubMed ID: 29174367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrasting effects of exercise, AICAR, and increased fatty acid supply on in vivo and skeletal muscle glucose metabolism.
    Rantzau C; Christopher M; Alford FP
    J Appl Physiol (1985); 2008 Feb; 104(2):363-70. PubMed ID: 18032581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creatine therapy in myophosphorylase deficiency (McArdle disease): a placebo-controlled crossover trial.
    Vorgerd M; Grehl T; Jager M; Muller K; Freitag G; Patzold T; Bruns N; Fabian K; Tegenthoff M; Mortier W; Luttmann A; Zange J; Malin JP
    Arch Neurol; 2000 Jul; 57(7):956-63. PubMed ID: 10891977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splice mutations preserve myophosphorylase activity that ameliorates the phenotype in McArdle disease.
    Vissing J; Duno M; Schwartz M; Haller RG
    Brain; 2009 Jun; 132(Pt 6):1545-52. PubMed ID: 19433441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased insulin action in skeletal muscle from patients with McArdle's disease.
    Nielsen JN; Vissing J; Wojtaszewski JF; Haller RG; Begum N; Richter EA
    Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1267-75. PubMed ID: 12006356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.